Supporting the efforts of the medical community in the face of the global pandemic, Globalpharma, a wholly-owned subsidiary of Dubai Investments PJSC, has proven readiness for manufacturing & providing indispensable medicines & medical necessities required to face the pandemic and its outcomes in the coming period.
Globalpharma has proven availability of the medicines aimed at aiding the battle against the international pandemic.
Globalpharma has proven research and consequently preparing the World Health Organization (WHO) present day recommended formulas in the manufacturing of the sanitizers. In parallel to scaling up operations to produce larger quantities, the Company is working intently with local producers and suppliers specialized in sanitizer production, enforcing a rapid manufacturing formula method at a larger scale, making sure well timed availability of the sanitizers locally. Local tests are being initiated to make sure best performance and safety.
The company is analyzing the probabilities of manufacturing and providing other medical requirements that will assist the efforts to curb the spread of COVD-19.
“As a responsible pharmaceutical company, we need to aid the government and the community with the best means of treatment and support. We have collaborated all our assets and are partnering with specialized producers to make sure a seamless manufacturing chain and offer well timed medical support”, stated Mohammed Saeed Al Raqbani, General Manager, Dubai Investments Industries.
Globalpharma manufactures and commercializes pharmaceutical products under CGMP (current good manufacturing practice) prerequisites such as antibiotics, cardiovascular, anti-ulcerants, analgesic, NSAIDs (Nonsteroidal anti-inflammatory medicines), food supplements, vitamins, anti-diabetics, respiratory products and anti-histamine formulations
“At Globalpharma we are well acknowledged for following the very best quality of good manufacturing practice (GMP) standards. We are eager on enforcing the same to the manufacturing procedure of the urgently needed high quality sanitizers and similar products”, stated Basem Al Barahmeh, General Manager, Globalpharma Co. L.L.C